During COVID, African healthtech attracted a wave of urgency and donor attention. It was natural to back apps and telemedicine pilots and assume ministries, NGOs or insurers would eventually pay for scale. The reality is more constrained: health budgets are tight everywhere, and out-of-pocket spend across the continent is limited.

Why Did African Healthtech Funding Fall So Sharply?

The numbers are stark. Healthtech funding in Africa fell about 70% year-on-year in 2024, down to roughly $65m from $212m in 2023, even though around $1bn has been invested in the category since 2019. At the same time, institutions like the African Development Bank committed about $1bn to health projects in 2024, including hospitals and digital tools, delivered through public-private partnerships. The capital has not vanished; it has moved into vehicles that tie innovation directly to reimbursable services in primary care, diagnostics and supply chains.

What Business Models Are Winning in African Healthtech?

The founders who will build lasting companies accept that they are selling into governments, donors and insurers first, and only later to consumers, and they design products, pricing and evidence accordingly.

What buyers will prioritise in 2026:

• Supply-chain and procurement platforms that reduce stockouts and wastage for ministries of health and large hospital groups, not just private pharmacies.
• Diagnostics and remote monitoring tools that integrate with national health records and can be reimbursed under existing donor or insurance schemes.
• Workforce tools that make nurses, community health workers and clinicians dramatically more productive, rather than trying to replace them.

Will Consumer-Facing Health Apps Succeed in Africa?

In African healthtech, polished apps with unclear business models will struggle to move beyond pilots. Solutions that sit on real budget lines and improve system efficiency will have the chance to reach scale.

Frequently Asked Questions

Q: What types of African healthtech startups are most likely to attract institutional funding in 2026?
Startups focused on supply-chain management, diagnostics integrated with national health records, and workforce productivity tools are best positioned. These solutions align with existing government and donor budget lines, making reimbursement pathways clearer and more reliable.

Q: How does African healthtech differ from healthtech in higher-income markets?
African healthtech operates in an environment where out-of-pocket consumer spending is limited and public health budgets are constrained. This means B2C app models that work in the US or Europe are less viable; successful African healthtech companies typically sell to governments, insurers, and donor organizations first.

Q: What role do public-private partnerships play in African healthtech funding?
Public-private partnerships are increasingly central to African healthtech financing. Institutions like the African Development Bank committed approximately $1bn to health projects in 2024 through such structures, channeling capital toward innovations tied directly to reimbursable primary care, diagnostic, and supply-chain services.

‍